Who
Mark G. Currie
Director
Company insider
Files Form 4 as: Chief Scientific Officer, Ironwood Pharmaceuticals; President and CSO, Cyclerion Therapeutics.
In numbers
- Trades disclosed
- 198
- Buys
- 1
- Sells
- 40
- Bought
- $4.0M
- Sold
- $24.6M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 2 Feb 2010
- Last trade
- 16 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —63,481 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —63,481 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —24,311 at $0.00 | filing |
| 20 Jun 2023filed 22 Jun 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —22,350 at $0.00 | filing |
| 11 Aug 2022filed 15 Aug 2022 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $825K70,000 at $11.78 | filing |
| 7 Jun 2022filed 9 Jun 2022 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —190,383 at $0.00 | filing |
| 7 Jun 2022filed 9 Jun 2022 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $2.2M190,383 at $11.65 | filing |
| 7 Jun 2022filed 9 Jun 2022 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $2.3M190,383 at $12.01 | filing |
| 1 Jun 2022filed 3 Jun 2022 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —21,571 at $0.00 | filing |
| 14 Jun 2021filed 16 Jun 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $273K23,571 at $11.59 | filing |
| 2 Jun 2021filed 4 Jun 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —22,766 at $0.00 | filing |
| 28 Dec 2020filed 30 Dec 2020 | Cyclerion TherapeuticsBiotechnology | SEC FORM 4 Sold | $61K20,107 at $3.01 | filing |
| 3 Jun 2020filed 5 Jun 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —21,720 at $0.00 | filing |
| 23 Jan 2020filed 24 Jan 2020 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —60,000 at $0.00 | filing |
| 23 Jan 2020filed 24 Jan 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $547K60,000 at $9.12 | filing |
| 23 Jan 2020filed 24 Jan 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $755K60,000 at $12.59 | filing |
| 16 Jan 2020filed 21 Jan 2020 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,888 at $0.00 | filing |
| 16 Jan 2020filed 21 Jan 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $89K8,888 at $10.02 | filing |
| 16 Jan 2020filed 21 Jan 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $114K8,888 at $12.80 | filing |
News
No headline names them, or the companies they trade most, lately.